Repeated doses of the perfluorocarbon FC-100 improve lung function of preterm lambs

Pediatric Research

Volumn 42, Issue 6, 1997, Pages 893-898

  Moya, Fernando R ^a,e   Llanos, Aníbal J ^b   Ríos, Antonio M ^c   Riquelme, Raquel A ^b   Moraga, Fernando A ^b   Rubio, Lilian A ^c   Salvo, Hugo D ^c   Jacobs, Harris C ^d  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF CHILE   (Chile)

^c HOSPITAL DEL SALVADOR   (Chile)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; BUPIVAN; FENTANYL; FLUOROCARBON; LUNG SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTRATRACHEAL DRUG ADMINISTRATION; LUNG ALVEOLUS SURFACE TENSION; LUNG FUNCTION; NONHUMAN; PHOSPHOLIPID MEMBRANE; PREMATURITY; PRIORITY JOURNAL; SENSITIZATION; SHEEP; SURVIVAL;

EID: 0030663368     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199712000-00028     Document Type: Article

References (32)

1. Jobe A, Ikegami M 1987 Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 136:1256-1275
2. Jobe AH 1993 Pulmonary surfactant therapy. N Engl J Med 328:861-868
3. Cummings JJ, Holm BA, Hudak ML, Hudak BB, Ferguson WH, and Egan EA 1992 A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis 145:999-1004
4. Yee WFH, Scarpelli EM 1991 Surfactant replacement therapy. Pediatr Pulmonol 11:65-80
5. Ikegami M, Agata Y, Elkady T, Hallman M, Berry D, and Jobe A 1987 Comparison of four surfactants: in vitro surface properties and responses of preterm lambs to treatment at birth. Pediatrics 79:38-46
6. Choukroun ML, Llanas B, Apere H, Fayon M. Galperine RI, Guenard H, Demarquez JL 1994 Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations. Pediatr Pulmonol 18:273-278
7. Jacobs HC, Berry DD, Duane G, Ikegami M, Jobe AH, and Jones S 1985 Normalization of arterial blood gases after treatment of surfactant deficient lambs with Tween 20. Am Rev Respir Dis 132:1313-1318
8. Mercurio MR, Fiascone JM, Lima DM, and Jacobs HC 1989 Surface tension and pulmonary compliance in premature rabbits. J Appl Physiol 66:2039-2044
9. Gladstone IM, Ray AO, Salafia CM, Pérez-Fontan J, Mercurio MR, Jacobs HC 1990 Effect of artificial surfactant on pulmonary function in preterm and full-term lambs. J Appl Physiol 69:465-472
10. Shaffer TH, Wolfson MR, Clark Jr LC 1992 Liquid Ventilation. Pediatr Pulmonol 14:102-109
11. Greenspan JS, Wolfson MR, Rubenstein SD, Shaffer TH 1990 Liquid ventilation of human preterm neonates. J Pediatr 117:106-111
12. Leach CL, Fuhrman BP, Morin III FC, Rath MG 1993 Perfluorocarbon-associated gas exchange (partial liquid ventilation) in respiratory distress syndrome: a prospective, randomized, controlled study. Crit Care Med 21:1270-1278
13. Jobe A, Ikegami M, Glatz T, Yoshida Y, Diakomanolis E, and Padbury J 1981 Duration and characteristics of treatment of premature lambs with natural surfactant. J Clin Invest 67:370-375
14. Leach CL, Holm B, Morin FC, Fuhrman BP, Papo MC, Steinhorn D, German LJ 1995 Partial liquid ventilation in premature lambs with respiratory distress syndrome: efficacy and compatibility with exogenous surfactant. J Pediatr 126:412-420
15. Stein HM, Oyama K, Martinez A, Chappell BA, Buhl E, Blount L, Padbury JF 1993 Effects of corticosteroids in preterm sheep on adaptation and sympathoadrenal mechanisms at birth. Am J Physiol 264:E763-E769
16. Zar JH 1984 Biostatistical Analysis, 2nd Ed. Prentice-Hall, Englewood Cliffs, NJ, pp 162-205
17. David JM, Veness-Meehan K, Notter RH, Bhutani VK, Kendig JW, Shapiro DL 1988 Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome. N Engl J Med 319:476-479
18. Cotton RB, Olsson T, Law AB, Parker RA, Lindstrom DP, Silberberg AR, Sundell HW, Sandberg K 1993 The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease. Pediatr Res 34:495-501
19. Tütüncü AS, Faithfull NS, Lachmann B 1993 Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: dose-dependent improvement of gas exchange. Crit Care Med 21:962-969
20. Leach CL, Greenspan JS, Rubenstein SD, Shaffer TH, Wolfson MR, Jackson JC, DeLemos R, Fuhrman BP 1996 Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med 335:761-767
21. Lang MJ, Hall RT, Reddy NS, Kurth CG, Merritt A 1990 A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants. J Pediatr 116:295-300
22. Durand DJ, Clyman RI, Heymann MA, Clements JA, Mauray F, Kitterman J, Ballard P 1985 Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs. J Pediatr 107:775-780
23. Ikegami M, Ueda T, Absolom D, Baxter C, Rider E, Jobe AH 1993 Changes in exogenous surfactant in ventilated preterm lamb lungs. Am Rev Respir Dis 148-837-844
24. Hall SB, Venkitaraman AR, Whitsett JA, Holm BA, Notter RH 1992 Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis 145:24-30
25. Long W, Corbel A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V, The American Exosurf Neonatal Study Group I, and The Canadian Exosurf Neonatal Study Group 1991 A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. N Engl J Med 325:1696-1703
26. The Osiris Collaborative Group 1992 Early versus delayed neonatal administration of a synthetic surfactant - the judgment of OSIRIS. Lancet 340:1363-1369
27. Ikegami M, Adams FH, Towers B, Osher AB 1980 The quantity of natural surfactant necessary to prevent the respiratory distress syndrome in premature lambs. Pediatr Res 14:1082-1085
28. Berry DD, Pramanik AK, Philips III JB, Buchter DS, Kanarek KS, Easa D, Kopelman AE, Edwards K, Long W, and the American Exosurf Neonatal Study Group II 1994 Comparison of the effect of three doses of a synthetic surfactant on the alveolar-arterial oxygen gradient in infants weighing a ≥1250 grams with respiratory distress syndrome. J Pediatr 124:294-301
29. Curtis SE, Peek JT, Kelly DR 1993 Partial liquid breathing with perflubron improves arterial oxygenation in acute canine lung injury. J Appl Physiol 75:2696-2702
30. Nesti FD, Fuhrman BP, Steinhorn DM, Papo MC, Hernan LJ, Duffy LC, Fisher JE, Leach CL, Paczan PR, Burak BA 1994 Perfluorocarbon-associated gas exchange in gastric aspiration. Crit Care Med 22:1445-1452
31. Branca D, Chiarelli SM, Vincent E, Tortorella C, Scutari G 1994 Alteration of mitochondrial bioenergetics due to intravenous injection of a perfluorocarbon emulsion. Experientia 50:660-663
32. Rios A, Llanos AJ, Moya FR, Navarrete C, Gaete C, Sanjueza E, Riquelme R, Jacobs HC 1993 Repeated doses of a perfluorocarbon improve arterial blood gases (ABG) and lung compliance (C) in preterm lambs (L). Pediatr Res 33:233A(abstr)